Sign in
4

Changes in Ownership

XTL BIOPHARMACEUTICALS LTD Filed Acc 0001144204-07-045600

CEO bought 15,279 shares at $1.30 ($19,863)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BENTSUR RON CEO 2007-08-21 Purchase +15,279 $1.30 $19,863 20,101 D
Open-market purchases · 15,279 sh · avg $1.30 · $19,863
Loading xslF345X02/v085834_ex.xml…